CONSULTING AGENT WARRANT MARIZYME, INC.Marizyme Inc • February 14th, 2022 • Pharmaceutical preparations
THIS CONSULTING AGENT WARRANT TO PURCHASE COMMON STOCK (the“Warrant”) certifies that, for value received ($100), Bradley Richmond, or its assigns (the “Holder”), is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after April 2, 2021 (the “Initial Exercise Date”) and prior to 5:00 p.m. (New York time) on the date that is five (5) years following the Initial Issuance Date (the “Termination Date”) but not thereafter, to subscribe for and purchase from Marizyme, Inc., a Delaware corporation (the “Company”), 36,364 shares of common stock, par value $0.0001 per share, of the Company, subject to adjustment (the “Warrant Shares”), as subject to adjustment hereunder. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).
ContractMarizyme Inc • February 14th, 2022 • Pharmaceutical preparations
THIS WARRANT HAS NOT BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT OR PURSUANT TO AN AVAILABLE EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT AND IN ACCORDANCE WITH APPLICABLE STATE SECURITIES LAWS AS EVIDENCED BY A LEGAL OPINION OF COUNSEL TO THE TRANSFEROR TO SUCH EFFECT, THE SUBSTANCE OF WHICH SHALL BE REASONABLY ACCEPTABLE TO THE COMPANY.
SECURITY AGREEMENTSecurity Agreement • February 14th, 2022 • Marizyme Inc • Pharmaceutical preparations
SECURITY AGREEMENT (this “Agreement”), dated as of May __, 2021, by and among Marizyme, Inc., a Nevada corporation (the “Company”) and the secured parties signatory hereto (collectively, the “Secured Party”).
GUARANTYGuaranty • February 14th, 2022 • Marizyme Inc • Pharmaceutical preparations • New York
GUARANTY (the “Guaranty”), dated as of May [ ], 2021, by among the guarantors signatory hereto (individually, a “Guarantor” and collectively, the “Guarantors”) in favor of the lenders signatory hereto (collectively, the “Lender”).
GUARANTORS SECURITY AGREEMENTGuarantors Security Agreement • February 14th, 2022 • Marizyme Inc • Pharmaceutical preparations
GUARANTORS SECURITY AGREEMENT (this “Agreement”), dated as of May 20, 2021, by and among the grantors signatory hereto (individually, a “Grantor” and collectively, the “Grantors”) and the secured parties signatory hereto (collectively, the “Secured Party”).
MARIZYME, INC. CONSULTING AGREEMENTConsulting Agreement • February 14th, 2022 • Marizyme Inc • Pharmaceutical preparations • Florida
THIS CONSULTING AGREEMENT (this “Agreement”) is entered into effective as of December 21, 2021 (“Effective Date”) by and among Marizyme, Inc. a Nevada corporation (the “Company”), Rydra Capital Corp., a corporation incorporated pursuant to the laws of British Columbia, Canada (“Rydra”) and Harrison Ross, an individual (“Principal” and together with Rydra, the “Consultant”). The Company together with the Consultant, the “Parties,” and each individually, a “Party”.
TRADEMARK SECURITY AGREEMENTTrademark Security Agreement • February 14th, 2022 • Marizyme Inc • Pharmaceutical preparations • New York
This TRADEMARK SECURITY AGREEMENT (this “Trademark Security Agreement”) is entered into as of May __, 2021 by and between MARIZYME, INC., a Nevada corporation (the “Grantor”) and secured parties signatory hereto (collectively, the “Secured Party”).
PATENT SECURITY AGREEMENTPatent Security Agreement • February 14th, 2022 • Marizyme Inc • Pharmaceutical preparations • New York
This PATENT SECURITY AGREEMENT (this “Patent Security Agreement”) is entered into as of May 19, 2021 by and among Marizyme, Inc., a Nevada corporation (the “Grantor”) and the secured parties signatory hereto (collectively, the “Secured Party”).
CONSULTING AGREEMENTConsulting Agreement • February 14th, 2022 • Marizyme Inc • Pharmaceutical preparations • New York
This Agreement, executed on September 30, 2020 (the “Agreement”) by and between Marizyme Inc., a corporation organized and existing under the laws of Nevada (hereinafter called “MRZM” or the “Company”) and Bradley Richmond (hereinafter, in the aggregate, the “Consultants”).
